Patent ID: 7888320

Claim:
A method of treating cancer comprising: intratumorally administering a therapeutically effective amount of a composition comprising: (i) a protein able to neutralize the binding of IL-10 to its receptor that is a soluble receptor for IL-10, an IL-3 protein, and a Toll-like receptor ligand, or (ii) a nucleic acid encoding the protein able to neutralize the binding of IL-10 to its receptor that is a soluble receptor for IL-10 and encoding the IL-3 protein, and a Toll-like receptor ligand, or (iii) a cell transformed by the nucleic acid (ii) and expressing the protein able to neutralize the binding of IL-10 to its receptor that is a soluble receptor for IL-10 and expressing the IL-3 protein, and a Toll-like receptor ligand, to a patient.